Cristal Therapeutics

company

About

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€6M
Industries
Biotechnology,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec. CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€18.80M
Cristal Therapeutics has raised a total of €18.80M in funding over 2 rounds. Their latest funding was raised on Jan 19, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 19, 2017 Series Unknown €12.80M 2 Detail
Dec 15, 2014 Series Unknown €6M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cristal Therapeutics is funded by 2 investors. Utrecht University Holding and Management Innovation Fund and Nedermaas Hightech Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Utrecht University Holding and Management Innovation Fund Series Unknown
Nedermaas Hightech Ventures Series Unknown